benserazide has been researched along with Edema in 3 studies
Benserazide: An inhibitor of DOPA DECARBOXYLASE that does not enter the central nervous system. It is often given with LEVODOPA in the treatment of parkinsonism to prevent the conversion of levodopa to dopamine in the periphery, thereby increasing the amount that reaches the central nervous system and reducing the required dose. It has no antiparkinson actions when given alone.
benserazide : A carbohydrazide that results from the formal condensation of the carboxy group of DL-serine with the primary amino group of 4-(hydrazinylmethyl)benzene-1,2,3-triol. An aromatic-L-amino-acid decarboxylase inhibitor (DOPA decarboxylase inhibitor) that does not enter the central nervous system, it is used as its hydrochloride salt as an adjunct to levodopa in the treatment of parkinsonism. By preventing the conversion of levodopa to dopamine in the periphery, it causes an increase in the amount of levodopa reaching the central nervous system and so reduces the required dose. Benserazide has no antiparkinson actions when given alone.
Edema: Abnormal fluid accumulation in TISSUES or body cavities. Most cases of edema are present under the SKIN in SUBCUTANEOUS TISSUE.
Excerpt | Relevance | Reference |
---|---|---|
"Pramipexole is a non-ergot dopamine agonist that is used frequently as a single therapy or in combination for the management of Parkinson's disease." | 5.38 | Pramipexole-related chronic lower limb oedema in a patient with Parkinson's disease. ( Munhoz, RP; Teive, HA; Zavala, JA, 2012) |
"Pramipexole is a non-ergot dopamine agonist that is used frequently as a single therapy or in combination for the management of Parkinson's disease." | 1.38 | Pramipexole-related chronic lower limb oedema in a patient with Parkinson's disease. ( Munhoz, RP; Teive, HA; Zavala, JA, 2012) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Zavala, JA | 1 |
Munhoz, RP | 1 |
Teive, HA | 1 |
Hirschelmann, R | 1 |
Thong, NT | 1 |
Barbeau, A | 1 |
Mars, H | 1 |
Gillo-Joffroy, L | 1 |
3 other studies available for benserazide and Edema
Article | Year |
---|---|
Pramipexole-related chronic lower limb oedema in a patient with Parkinson's disease.
Topics: Ankle; Antiparkinson Agents; Benserazide; Benzothiazoles; Drug Therapy, Combination; Edema; Humans; | 2012 |
Influence of dopaminergic anti-Parkinsonian agents on inflammatory reactions in rats.
Topics: Animals; Antiparkinson Agents; Arthritis, Experimental; Benserazide; Bromocriptine; Carrageenan; Dop | 2000 |
Adverse clinical side effects of levodopa therapy.
Topics: Antiparkinson Agents; Arrhythmias, Cardiac; Benserazide; Carboxy-Lyases; Dihydroxyphenylalanine; Ede | 1971 |